Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Array BioPharma, Celgene in Global R&D Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Array BioPharma, Celgene in Global R&D Alliance

Development program to target novel inflammation pathway

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Array BioPharma, Inc. has entered a strategic collaboration with Celgene Corp. for its preclinical development program targeting a novel inflammation pathway. Array will receive an upfront payment of $11 million and Celgene will have an exclusive option to license multiple clinical development candidates. Array is eligible to receive potential milestone payments of as much as $376 million based certain development, regulatory and sales objectives. Array is also entitled to receive royalties on sales and will retain all rights to the program if Celgene does not exercise its option.
 
“We are pleased to announce this new collaboration with Celgene focused on a novel inflammation pathway,” said Kevin Koch, Ph.D., president and chief scientific officer, Array BioPharma. “Given Celgene’s global leadership and expertise in the development and commercialization of innovative therapies and Array’s solid track record of inventing and progressing targeted drugs into clinical trials, we believe this alliance will maximize the value of a very exciting and innovative program.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics